Increased urinary IgM excretion in patients with chest pain due to coronary artery disease

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Tofik, Rafid ^a   Ekelund, Ulf ^a   Torffvit, Ole ^a   Swärd, Per ^a   Rippe, Bengt ^a   Bakoush, Omran ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Acute coronary syndrome; Cardiovascular mortality; Chest pain; Microalbuminuria; Urine IgM

Indexed keywords

ALBUMIN; CREATININE; IMMUNOGLOBULIN M;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE URINE LEVEL; EXERCISE TEST; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; MYOCARDIAL PERFUSION IMAGING; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; THORAX PAIN; UNSTABLE ANGINA PECTORIS; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEST PAIN; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84883707725     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-72     Document Type: Article

References (31)

1. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart 2005, 91:229-230. 10.1136/hrt.2003.027599, 1768669, 15657244.
2. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report 2010, 26:1-31.
3. Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Jneid H, Lincoff AM, et al. ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 57:1920-1959. 10.1016/j.jacc.2011.02.009, 21450428.
4. Elmehdawi RR, Albarsha AM. Obesity in Libya: a review. Libyan J Med 2012, 7:19086.
5. Ekelund U, Nilsson HJ, Frigyesi A, Torffvit O. Patients with suspected acute coronary syndrome in a university hospital emergency department: an observational study. BMC Emerg Med 2002, 2:1. 10.1186/1471-227X-2-1, 130966, 12361481.
6. Gosling P, Hughes EA, Reynolds TM, Fox JP. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991, 12:508-513.
7. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007, 2:581-590. 10.2215/CJN.03190906, 17699466.
8. Solbu MD, Kronborg J, Jenssen TG, Njolstad I, Lochen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis 2009, 204:503-508. 10.1016/j.atherosclerosis.2008.11.002, 19091314.
9. Liu CS, Pi-Sunyer FX, Li CI, Davidson LE, Li TC, Chen W, Lin CC, Huang CY, Lin WY. Albuminuria is strongly associated with arterial stiffness, especially in diabetic or hypertensive subjects-a population-based study (Taichung Community Health Study, TCHS). Atherosclerosis 2010, 211:315-321. 10.1016/j.atherosclerosis.2010.02.015, 20226463.
10. Sharma M, McCarthy ET, Savin VJ, Lianos EA. Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide. Kidney Int 2005, 68:2735-2744. 10.1111/j.1523-1755.2005.00744.x, 16316348.
11. Tofik R, Torffvit O, Rippe B, Bakoush O. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy. Diabetes Res Clin Pract 2012, 95:139-144. 10.1016/j.diabres.2011.10.008, 22078636.
12. Tofik R, Torffvit O, Rippe B, Bakoush O. Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy. BMC Med 2009, 7:39. 10.1186/1741-7015-7-39, 2729477, 19653885.
13. Bakoush O, Segelmark M, Torffvit O, Ohlsson S, Tencer J. Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis. Nephrol Dial Transplant 2006, 21:1263-1269. 10.1093/ndt/gfk074, 16449276.
14. Tencer J, Thysell H, Grubb A. Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest 1996, 56:691-700. 10.3109/00365519609088816, 9034350.
15. Nilsson PM, Engstrom G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions. Diabet Med 2007, 24:464-472. 10.1111/j.1464-5491.2007.02142.x, 17381496.
16. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003. 10.1016/S0195-668X(03)00114-3, 12788299.
17. Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators Inflamm 2009, 2009:584916. 2706009, 19587833.
18. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008, 88:451-487. 10.1152/physrev.00055.2006, 18391170.
19. Rippe C, Rippe A, Larsson A, Asgeirsson D, Rippe B. Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats. Am J Physiol 2006, 291:F1362-F1368.
20. Rippe C, Rippe A, Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in early experimental diabetes in rats. Am J Physiol Renal Physiol 2007, 293:F1533-F1538. 10.1152/ajprenal.00271.2007, 17699552.
21. Axelsson J, Rippe A, Venturoli D, Sward P, Rippe B. Effects of early endotoxemia and dextran-induced anaphylaxis on the size selectivity of the glomerular filtration barrier in rats. Am J Physiol 2009, 296:F242-F248.
22. Axelsson J, Mahmutovic I, Rippe A, Rippe B. Loss of size selectivity of the glomerular filtration barrier in rats following laparotomy and muscle trauma. Am J Physiol 2009, 297:F577-F582.
23. Axelsson J, Rippe A, Rippe B. Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats. Am J Physiol Renal Physiol 2010, 298:F1306-F1312. 10.1152/ajprenal.00710.2009, 20237233.
24. Axelsson J, Rippe A, Rippe B. Transient and sustained increases in glomerular permeability following ANP infusion in rats. Am J Physiol Renal Physiol 2011, 300:F24-F30. 10.1152/ajprenal.00347.2010, 20943768.
25. Axelsson J, Rippe A, Oberg CM, Rippe B. Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats. Am J Physiol Renal Physiol 2012, 303:F790-F799. 10.1152/ajprenal.00153.2012, 22718887.
26. Tencer J, Frick IM, Oquist BW, Alm P, Rippe B. Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways. Kidney Int 1998, 53:709-715. 10.1046/j.1523-1755.1998.00797.x, 9507218.
27. Kuo HK, Al Snih S, Kuo YF, Raji MA. Chronic inflammation, albuminuria, and functional disability in older adults with cardiovascular disease: the National Health and Nutrition Examination Survey, 1999-2008. Atherosclerosis 2012, 222:502-508. 10.1016/j.atherosclerosis.2012.03.004, 22460050.
28. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L, Investigators FI. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001, 38:979-986. 10.1016/S0735-1097(01)01501-7, 11583868.
29. Al-Aqeedi RF, Abdullatef WK, Dabdoob W, Bener A, Albinali HA, Gehani A. The prevalence of metabolic syndrome components, individually and in combination, in male patients admitted with acute coronary syndrome, without previous diagnosis of diabetes mellitus. Libyan J Med 2013, 8:20185. 3604448, 23517754.
30. Than M, Cullen L, Reid CM, Lim SH, Aldous S, Ardagh MW, Peacock WF, Parsonage WA, Ho HF, Ko HF, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 2011, 377:1077-1084. 10.1016/S0140-6736(11)60310-3, 21435709.
31. Giallauria F, Lucci R, D'Agostino M, Vitelli A, Maresca L, Mancini M, Aurino M, Del Forno D, Giannuzzi P, Vigorito C. Two-year multicomprehensive secondary prevention program: favorable effects on cardiovascular functional capacity and coronary risk profile after acute myocardial infarction. J Cardiovasc Med 2009, 10:772-780.